U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 090134
Company: ACTAVIS ELIZABETH
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE EQ 75MG BASE TABLET, DELAYED RELEASE;ORAL Prescription AB No No
DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE EQ 100MG BASE TABLET, DELAYED RELEASE;ORAL Prescription AB No No
DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE EQ 50MG BASE TABLET, DELAYED RELEASE;ORAL Prescription AB No No
DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE EQ 200MG BASE TABLET, DELAYED RELEASE;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
12/14/2011 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
04/12/2024 SUPPL-26 Labeling-Package Insert

Label is not available on this site.

04/12/2024 SUPPL-23 Labeling-Package Insert

Label is not available on this site.

01/13/2021 SUPPL-21 Labeling-Package Insert

Label is not available on this site.

03/27/2018 SUPPL-18 Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/090134Orig1s018ltr.pdf
12/27/2017 SUPPL-17 Labeling-Package Insert

Label is not available on this site.

12/27/2017 SUPPL-15 Labeling-Package Insert

Label is not available on this site.

12/27/2017 SUPPL-14 Labeling-Package Insert

Label is not available on this site.

04/22/2014 SUPPL-11 Labeling-Package Insert

Label is not available on this site.

DOXYCYCLINE HYCLATE

TABLET, DELAYED RELEASE;ORAL; EQ 75MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE EQ 75MG BASE TABLET, DELAYED RELEASE;ORAL Prescription No AB 090134 ACTAVIS ELIZABETH
DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE EQ 75MG BASE TABLET, DELAYED RELEASE;ORAL Prescription No AB 213075 ALEMBIC
DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE EQ 75MG BASE TABLET, DELAYED RELEASE;ORAL Prescription No AB 200856 HERITAGE PHARMS

TABLET, DELAYED RELEASE;ORAL; EQ 100MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE EQ 100MG BASE TABLET, DELAYED RELEASE;ORAL Prescription No AB 090134 ACTAVIS ELIZABETH
DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE EQ 100MG BASE TABLET, DELAYED RELEASE;ORAL Prescription No AB 213075 ALEMBIC
DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE EQ 100MG BASE TABLET, DELAYED RELEASE;ORAL Prescription No AB 200856 HERITAGE PHARMS

TABLET, DELAYED RELEASE;ORAL; EQ 50MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE EQ 50MG BASE TABLET, DELAYED RELEASE;ORAL Prescription No AB 090134 ACTAVIS ELIZABETH
DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE EQ 50MG BASE TABLET, DELAYED RELEASE;ORAL Prescription No AB 207494 PRINSTON INC

TABLET, DELAYED RELEASE;ORAL; EQ 200MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
DORYX DOXYCYCLINE HYCLATE EQ 200MG BASE TABLET, DELAYED RELEASE;ORAL Prescription Yes AB 050795 MAYNE PHARMA
DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE EQ 200MG BASE TABLET, DELAYED RELEASE;ORAL Prescription No AB 090134 ACTAVIS ELIZABETH
DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE EQ 200MG BASE TABLET, DELAYED RELEASE;ORAL Prescription No AB 213075 ALEMBIC
DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE EQ 200MG BASE TABLET, DELAYED RELEASE;ORAL Prescription No AB 200856 HERITAGE PHARMS
DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE EQ 200MG BASE TABLET, DELAYED RELEASE;ORAL Prescription No AB 207494 PRINSTON INC
Back to Top